HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hourcade, D. E. Articles by Oglesby, T. J. Search for Related Content PubMed PubMed Citation Articles by Hourcade, D. E. Articles by Oglesby, T. J. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 40, 25996-26000, October 2, 1998

A Conserved Element in the Serine Protease Domain of Complement Factor B

From the Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Factor B and C2 are serine proteases that carry the catalytic sites of the complement C3 and C5 convertases. Their protease domains are activated by conformational changes that occur during convertase assembly and are deactivated upon convertase dissociation. Factor B and C2 share an 8-amino acid conserved sequence near their serine protease termini that is not seen in other serine proteases. To determine its importance, 24 factor B mutants were generated, each with a single amino acid substitution in this region. Whereas most mutants were functionally neutral, all five different substitutions of aspartic acid 715 and one phenylalanine 716 substitution severely reduced hemolytic activity. Several aspartic acid 715 mutants permitted the steps of convertase assembly including C3b-dependent factor D-mediated cleavage and activation of the high affinity C3b-binding site, but the resulting complexes did not cleave C3. Given that factor B and C2 share the same biological substrates and that part of the trypsin-like substrate specificity region is not apparent in either protein, we propose that the conserved region plays a critical role in the conformational regulation of the catalytic site and could offer a highly specific target for the therapeutic inhibition of complement.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				E. Torreira, A. Tortajada, T. Montes, S. R. de Cordoba, and O. Llorca 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase PNAS, January 20, 2009; 106(3): 882 - 887. [Abstract] [Full Text] [PDF]

				D. Spitzer, L. M. Mitchell, J. P. Atkinson, and D. E. Hourcade Properdin Can Initiate Complement Activation by Binding Specific Target Surfaces and Providing a Platform for De Novo Convertase Assembly J. Immunol., August 15, 2007; 179(4): 2600 - 2608. [Abstract] [Full Text] [PDF]

				Y. Xu, A. Circolo, H. Jing, Y. Wang, S. V. L. Narayana, and J. E. Volanakis Mutational Analysis of the Primary Substrate Specificity Pocket of Complement Factor B. ASP226 IS A MAJOR STRUCTURAL DETERMINANT FOR P1-ARG BINDING J. Biol. Chem., January 7, 2000; 275(1): 378 - 385. [Abstract] [Full Text] [PDF]

				D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby Mutations of the Type A Domain of Complement Factor B That Promote High-Affinity C3b-Binding J. Immunol., March 1, 1999; 162(5): 2906 - 2911. [Abstract] [Full Text] [PDF]

				D. E. Hourcade, L. Mitchell, L. A. Kuttner-Kondo, J. P. Atkinson, and M. E. Medof Decay-accelerating Factor (DAF), Complement Receptor 1 (CR1), and Factor H Dissociate the Complement AP C3 Convertase (C3bBb) via Sites on the Type A Domain of Bb J. Biol. Chem., January 4, 2002; 277(2): 1107 - 1112. [Abstract] [Full Text] [PDF]